Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a23d0dfd7baab965

Jump to content

Talk:NK012

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 8 years ago by HighFlyingFish in topic Could NK012 be Onivyde - unlikely

mechanism and rational

[edit]

Can we say something about how it works and why it should be effective, and against what types of tumors ? Rod57 (talk) 01:49, 7 December 2010 (UTC)Reply

Maybe starting with nk012 if confirmed by 10p detailed - Rod57 (talk) 04:18, 3 December 2012 (UTC)Reply

Could NK012 be Onivyde - unlikely

[edit]

Could NK012 be Onivyde : "On October 22, 2015, the FDA approved irinotecan liposome injection (Onivyde)"  ? - Rod57 (talk) 03:25, 12 March 2016 (UTC)Reply

It appears they are different. Onivyde encapsulates irinotecan, while NK012 encapsulates SN-38. Further, NK012 got orphan drug status after Onivyde was approved, which I think indicates a separate development pathway. --HighFlyingFish (talk) 07:22, 24 November 2017 (UTC)Reply